More than one-quarter of pediatric patients on ventricular assist devices were able to have their devices explanted due to a ...

New concepts in device therapy for advanced heart failure presented in early reports ...

Patients with cardiogenic shock treated at hospitals with a higher volume of percutaneous microaxial VAD implantation in the US have lower mortality risk. Higher hospital procedure volume of ...

Pediatric ventricular assist devices (VADs) and mechanical circulatory support systems have emerged as critical tools in the management of children with end‐stage heart failure, including those with ...

Every year, around 50,000 people in the United States experience cardiogenic shock - a life-threatening condition, usually caused by a severe heart attack, in which the heart can't pump enough blood ...

Please provide your email address to receive an email when new articles are posted on . The FDA and Medtronic alerted health care providers to no longer implant patients with end-stage HF with a ...

CINCINNATI (WKRC) - Breakthrough technology is transforming the lives of local heart failure patients, offering new hope and improved quality of life. The TriHealth Heart and Vascular Institute is at ...

ANN ARBOR, Mich. — A cardiac surgery and heart failure team at the University of Michigan implanted a novel mechanical heart pump into a patient as part of a clinical trial that will compare it to the ...

Outcomes and expenses were similar with transplant and elective LVAD, but urgent LVAD after ECMO fared much worse.